ERIC
European Research Initiative on CLL
Project 7 (WP7) of the European LeukemiaNet (ELN) and
EHA Scientific Working Group (SWG)
The ERIC is an European organization devoted to improve the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.
There are many more open questions and new drugs available in the treatment of CLL than study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is a key element.
The ERIC is currently funded by the European LeukemiaNet (ELN) and is a Scientific Working Group (SWG) of the European Hematology Association (EHA). The ERIC is OPEN to every physician or scientist working/interested in the field of chronic lymphocytic leukemia or related disorders.